NASDAQ:HTCO

Caravelle International Group Announces Termination of Agreement with CUEX Metal AG

SINGAPORE, Oct. 24, 2024 /PRNewswire/ -- Caravelle International Group ("the Company", Nasdaq: HTCO), a global ocean technology company, today announced the termination of its Ore Sourcing Agreement with CUEX Metal AG. This agreement, initially disclosed on the Company's website onApril 18, 2024,...

2024-10-24 23:18 1594

Week's Top Stories

Most Reposted

Hundreds of Indonesian In-House Counsel Discuss Business Dynamics in Light of New Administration

[Picked up by 310 media titles]

2024-10-21 16:46
Hundreds of Indonesian In-House Counsel Discuss Business Dynamics in Light of New Administration

Asian Tigers Group Launches "The Global Move" Podcast Alongside AI-Enhanced Online Support

[Picked up by 275 media titles]

2024-10-22 06:30
Asian Tigers Group Launches

The China-Malaysia youth exchange delegation visited Jiangxi

[Picked up by 260 media titles]

2024-10-21 11:00

Chinese Firms Commended for Their Green Development and Digital Transformation Efforts at World Media Summit

[Picked up by 258 media titles]

2024-10-21 22:09
Chinese Firms Commended for Their Green Development and Digital Transformation Efforts at World Media Summit

Eating and Praising Along the Way! Korean Uncle Wants to Open a "Nanchang Restaurant"

[Picked up by 240 media titles]

2024-10-20 12:00

Most Read

Hundreds of Indonesian In-House Counsel Discuss Business Dynamics in Light of New Administration

2024-10-21 16:46 5646
Hundreds of Indonesian In-House Counsel Discuss Business Dynamics in Light of New Administration

Wow Jiangxi | Discover the sweet secret of Zixi Bread

2024-10-20 08:00 4315

Asia's largest Gifts & Home Fair opens today in Shenzhen

2024-10-20 14:00 4253

Eating and Praising Along the Way! Korean Uncle Wants to Open a "Nanchang Restaurant"

2024-10-20 12:00 4231

Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)

2024-10-22 18:00 4143